Homocysteine levels, haemostatic risk factors and restenosis after carotid thrombendarterectomy

European Journal of Vascular and Endovascular Surgery

Volumn 28, Issue 3, 2004, Pages 323-328

  Laxdal, Elin ^a   Eide, G E ^a   Amundsen, S R ^a   Dregelid, E B ^a   Pedersen, G ^a   Jonung, T ^b   Aune, S ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Atherosclerosis; Carotid thrombendarterectomy; Homocysteine; Restenosis; Survival analysis

Indexed keywords

ACTIVATED PROTEIN C; D DIMER; FIBRINOGEN; HOMOCYSTEINE;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; AMINO ACID BLOOD LEVEL; ANALYSIS OF VARIANCE; ARTICLE; BRAIN CIRCULATION; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DATA ANALYSIS; DIET RESTRICTION; DISEASE ASSOCIATION; ECHOGRAPHY; ENDARTERECTOMY; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HEMOSTASIS; HUMAN; ISCHEMIC HEART DISEASE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN METABOLISM; RESTENOSIS; RISK FACTOR; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; STROKE; STUDENT T TEST; SYMPTOMATOLOGY; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; FEMALE; HEMOSTASIS; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; TIME FACTORS; VASCULAR PATENCY;

EID: 4043145843     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejvs.2004.06.012     Document Type: Article

References (55)

1. Ballotta E. Da Giau G. Baracchini C. Manara R. Carotid eversion endarterectomy: perioperative outcome and restenosis incidence Ann Vasc Surg 16 4 2002 422-429
2. Katras T. Baltazar U. Rush D.S. Sutterfield W.C. Harvill L.M. Stanton P.E. Jr. Durability of eversion carotid endarterectomy: comparison with primary closure and carotid patch angioplasty J Vasd Surg 34 3 2001 453-458
3. AbuRahma A.F. Robinson P.A. Mullins D.A. Holt S.M. Herzog T.A. Mowery N.T. Frequency of postoperative carotid duplex surveillance and type of closure: results from a randomized trial J Vasc Surg 32 6 2000 1043-1051
4. Trisal V. Paulson T. Hans S.S. Mittal V. Carotid artery restenosis: an ongoing disease process Am Surg 68 3 2002 275-279 discussion 279-80
5. van den Berg M. Stehouwer C.D.A. Bierdrager E. Rauwerda J.A. Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease Arterioscler Thromb Vasc Biol 16 1996 165-171
6. Clarke R. Daly L. Robinson K. Cahalane S. Fowler B. et al. Hyperhomocysteinemia: an independent risk factor for vascular disease N Engl J Med 324 1991 1149-1155
7. Malinow M.R. Nieto F.J. Szklo M. Chambless L.E. Bond G. Carotid artery intimal-medial wall thickening and plasma homocysteine in asymptomatic adults. The atherosclerosis risk in communities study Circulation 87 1993 1107-1113
8. Taylor L.M. Moneta G.L. Sexton G.J. Schuff R.A. Porter J.M. The Homocysteine and Progression of Atherosclerosis Study Investigators. Prospective blinded study if the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease J Vasc Surg 29 1999 8-21
9. Kumbasar S.D. Dincer I. Ertas F. Gulec S. Erol C. Akyurek O. Kilickap M. Oral D. Sipahi E. Laleli Y. Hyperhomocysteinemia and restenosis J Cardiovasc Risk 8 2001 9-13
10. Giannetti N. Herity N.A. Alimolla A. Gao S.Z. Schroeder J.S. Yeung A.C. Hunt S.A. Valantine H.A. Mild hyperhomocysteinemia is not associated with cardiac allograft coronary disease Clin Transplant 15 2001 247-252
11. Zairis M.N. Ambrose J.A. Manousakis S.J. Stefanidis A.S. Papadaki O.A. Billanou H.I. Devoe M.C. et al. The impact of plasma levles of C reactive protein, lipoprotein (a) and homocysteine on the long term prognosis after successful coronary stenting. The global evaluation of new events and restenosis after stent implantation study J Am Coll Cardiol 40 2002 1375
12. Iwama Y. Mokuno H. Watnabe Y. Shimada K. Yokoi H. Daida H. Hosoda Y. Yamaguchi H. Relationship between plasma homocysteine levels and saphenous vein graft disease after coronary artery bypass grafts Jpn Heart J 42 2001 553-562
13. de Borst G.J. Tangelder M.J.D. Algra A. Lawson J.A. Banga J.D. Eikelboom B.C. van der Vliet J.A. Dutch BOA Study Group. The influence of hyperhomocysteinemia on graft patency after infrainguinal bypass surgery in the Dutch BOA Study J Vasc Surg 36 2002 336-340
14. Beattie D.K. Sian M. Greenhalg R.M. Davies A.H. Influence of systemic factors on pre-existing intimal hyperplasia and their effect on the outcome of infraiguinal arterial reconstruction with vein Br J Surg 86 1999 1441-1447
15. Irvine C. Wilson Y.G. Currie I.C. McGrath C. Scott J. Day A. et al. Hyper-homocysteinemia is a risk factor for vein graft stenosis Eur J Vasc Endovasc Surg 12 1996 304-309
16. Currie I.C. Wilson Y.G. Scott J. Day A. Stansbie D. Baird R.N. at al. Homocysteine: an independent risk factor for the failure of vascular intervention Br J Surg 83 1996 1238-1241
17. Hennerici M. Neuerburger-Heusler D. Vascular diagnosis with ultrasound 1998 Thieme Medical Publishers Stuttgart
18. Kaplan E.L. Meier P. Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457-481
19. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 50 1966 113-170
20. Cox D.R. Regression models and life tables (with discussion) J R Stat Soc, Ser B 34 1972 187-220
21. McCully K.S. Vascular pathology of homocysteinemia: implications for the pathogenesis of atherosclerosis Am J Pathol 56 1969 111-128
22. Fowler B. Kraus J. Packman S. Rosenberg L.E. Homocysteinuria. Evidence for three distinct classes of cystathionine β synthase mutants in cultured fibroblasts J Clin Invest 61 1978 645-653
23. Jacob R.A. Wu M.M. Henning S.M. Swenneseid M.E. Homocysteine increases as folate decreases in plasma of healthy men during short-term dietary folate and methyl group restriction J Nutr 124 1994 1072-1080
24. Miller J.W. Ribaya-Mercado J.D. Russel R.M. Shepard D.C. Morrow F.D. Cochary E.F. et al. Effect of vitamin B6 deficiency on fasting plasma homocysteine concentrations Am J Clin Nutr 55 1992 1154-1160
25. Brattstrom L. Israelson B. Lindgarde F. Hultberg B. Higher plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocysteinuria due to cystathionine β synthase deficiency Metabolism 37 1988 175-178
26. Brattstrom L. Vitamins as homocysteine-lowering agents J Nutr 126 1996 S1276-S1280
27. Doshi S.N. McDowell I.F.W. Moat S.J. Payne N. Durrant H.J. Lewis M.J. Goodfellow J. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering Circulation 105 2002 22-26
28. Scnyder G. Roffi M. Flammer Y. Pin R. Eberli F.R. Meier B. Turi Z.B. Hess O.M. Effect of homocysteine-lowering therapy on restenosis after percutaneous coronary innervention for narrowings in small coronary arteries Am J Cardiol 91 2003 1265-1269
29. Schnyder G. Roffi M. Flammer Y. Pin R. Hess O.M. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial JAMA 288 2002 973-979
30. Genser D. Prachar H. Hauer R. Halbmayer W. Miczoch J. Elmadfa I. Relation of homocysteine, vitamin B12 and folate to coronary in-stent restenosis Am J Cardiol 89 2002 495-499
31. Clarke R. Daly L. Robinson K. Cahalane S. Fowler B. et al. Hyperhomocysteinemia: an independent risk factor for vascular disease N Engl J Med 324 1991 1149-1155
32. Pancharunti N. Lewis C.A. Sauerlich H.E. Perkins L.L. Go R.C. Alvarez J.O. et al. Plasma homocystine, folate and vitamin B-12 concentration and risk for early-onset coronary artery disease Am J Clin Nutr 59 1994 940-948
33. Stamper M.J. Malinow M.R. Willett W.C. Newcomer L.M. Upson B. Ullmann D. et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians JAMA 268 1992 877-881
34. Selhub J. Jacques P.F. Bostom A.G. D'agostino R.B. Wilson P.W. Belanger A.J. et al. Association between plasma homocysteine concentration and extracranial carotid artery stenosis N Engl J Med 332 1995 286-291
35. Nygard O. Nordrehaug J.E. Refsum H. Ueland P.M. Farstad M. Voliset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease N Engl J Med 337 1997 230-236
36. Taylor L.M. DeFrang R.D. Harris E.J. Porter J.M. The association of elevated plasma homocysteine with progression of symptomatic peripheral artery disease J Vasc Surg 13 1991 128-136
37. Ridker P.M. Stampfer M.J. Rifai N. Novel risk factors for systemic atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine lipoprotein (a), and standard cholesterol screening as predictors for peripheral arterial disease JAMA 285 2001 2481-2485
38. Chasan-Taber L. Seihub J. Rosenberg I.H. Malinow R. Terry P. Tishler P.V. et al. A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians J Am Coll Nutr 15 1996 136-143
39. O'Grady H. Kelly C. Bouchier-Hayes D. Leahy A. Homocysteine and occlusive arterial disease Br J Surg 89 2002 838-844
40. Wang H. Yoshiumi M. Lai K. et al. Inhibition of growth and p21ras methylation in vascular smooth muscle cells by homocysteine but not cysteine J Biol Chem 272 1997 25380-25385
41. Tsai J.C. Perella M.A. Yoshizumi M. et al. Promotion of vascular smooth cell growth by homocysteine: a link to atherosclerosis Proc Natl Acad Sci USA 91 1994 6369-6373
42. Hultberg B. Anderson A. Isaksson A. The cell damaging effects of low amounts of homocysteine and copper irons in hum cell line cultures are caused by oxidative stress Toxicology 123 1997 33-40
43. Upchurch G.R. Jr. Welch G.N. Loscalzo J. Homocysteine, EDRF, and endothelial function J Nutr 126 1996 1290S-1294S
44. Loscalzo J. The oxidant stress of hyperhomocysteinemia J Clin Invest 98 1996 5-7
45. Vadiveloo P.K. Filonzi E.L. Stanton H.R. Hamilton J.A. G1 phase arrest of human smooth muscle cells by heparin, II-4, and cAMP is linked to a repression of cyclin D 1 and cdk2 Atherosclerosis 133 1997 61-69
46. Nishinaga M. Ozawa T. Shimada K. Homocysteine, a thrombogenic agent, suppresses anticoagulant heparin sulphate expression in cultured porcine aortic endothelial cells J Clin Invest 133 1993 61-69
47. Hajjar K.A. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor J Clin Invest 91 1993 2873-2879
48. Lentz S.R. Sadler J.E. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine J Clin Invest 88 1991 1906-1914
49. Lentz S.R. Sadler J.R. Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmatic reticulum Blood 81 1993 683-689
50. Tawacol A. Omland T. Gerhard M. Wu J.T. Creager M.A. Hyperhomoeysteinemia is associated with impaired endothelium-dependent vasodilatation in humans Circulation 95 1997 1119-1121
51. Lentz S.R. Sobey S.G. Piegors D.J. et al. Vascular dysfunction in monkeys with diet-induced hyperhomocysteinemia J Clin Invest 98 1996 24-29
52. Tsakiris D.A. Tschöpl M. Jäger K. Haefeli W.E. Wolf F. Marbet G.A. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease Atherosclerosis 142 1999 193-200
53. Southern F.N. Cruz N. Fink L.M. Cooney C.A. Barone G.W. Eidt J.F. Moursi M.M. Hyperhomocysteinemia increases intimal hyperplasia in rat carotid endarterectomy model J Vasc Surg 28 1998 909-918
54. Smith T.P. Cruz C.P. Brown A.T. Eidt J. Moursi M.M. Folate supplementation inhibits intimal hyperplasia induced by high-homocysteine diet in rat carotid endarterectomy model J Vasc Surg 34 2001 474-481
55. Royo T. Martinez-Gonzàlez J. Vilahur G. Badimon L. Differential intracellular trafficking of von Willebrand factor (vWF) and vMF propeptide in porcine endothelial cells lacking Weibel-Palade bodies and in human endothelial cells Atherosclerosis 167 2003 55-63